(BN) *PUTIN CALLS TO POSTPONE MAY 11 REFERENDUM TO EASE UKRAINE TALKS

+------------------------------------------------------------------------------+

BN 05/07 13:31 *OSCE TO PROPOSE ROAD MAP ON UKRAINE, BURKHALTER SAYS BN 05/07 13:30 *PUTIN: UKRAINE ELECTION WON'T HELP IF RIGHTS NOT GUARANTEED BN 05/07 13:26 *PUTIN: UKRAINE PRESIDENTIAL ELECTION MOVE IN RIGHT DIRECTION BFW 05/07 13:24 *PUTIN CALLS TO POSTPONE REFERENDUM IN SOUTH, EAST UKRAINE BN 05/07 13:24 *PUTIN CALLS TO POSTPONE REFERENDUM IN SOUTH, EAST UKRAINE BFW 05/07 13:23 *PUTIN SAYS UKRAINE NEEDS DIRECT DIALOG WITH SOUTH, EAST REGIONS BN 05/07 13:23 *PUTIN SAYS UKRAINE NEEDS DIRECT DIALOG WITH SOUTH, EAST REGIONS BN 05/07 13:22 *PUTIN CALLS ON UKRAINE TO STOP MILITARY OPERATION BN 05/07 13:22 *PUTIN SAYS RUSSIA, OSCE APPROACHES TO UKRAINE COINCIDE BN 05/07 13:20 *PUTIN SAYS ALL ARE INTERESTED IN RESOLVING UKRAINE CRISIS BFW 05/07 13:19 *PUTIN SAYS UKRAINE CRISIS DEVELOPING ALONG UNFAVORABLE SCENARIO BN 05/07 13:19 *PUTIN SAYS UKRAINE CRISIS DEVELOPING ALONG UNFAVORABLE SCENARIO

+------------------------------------------------------------------------------+

*PUTIN CALLS TO POSTPONE MAY 11 REFERENDUM TO EASE UKRAINE TALKS 2014-05-07 13:25:23.851 GMT

--TORREY CLARK

-0- May/07/2014 13:25 GMT

>>> Allergan beats by $0.06, beats on revs; guides Q2 EPS above consensus; raise

Allergan beats by $0.06, beats on revs; guides Q2 EPS above consensus; raises FY14 guidance (166.32)
Reports Q1 (Mar) earnings of $1.18 per share, excluding non-recurring items, vs. $1.09-1.12 guidance, $0.06 better than the Capital IQ Consensus of $1.12; revenues rose 12.7% year/year to $1.65 bln vs the $1.61 bln consensus. Total product net sales $1.62 bln vs. $1.525-1.60 bln guidance.
  • On April 22, 2014, Allergan confirmed receipt of an unsolicited proposal from Valeant Pharma (VRX) to acquire all of the outstanding shares of Allergan for a combination of 0.83 of Valeant common shares and $48.30 in cash per share of common stock of Allergan. The Allergan Board of Directors, in consultation with its financial and legal advisors, will carefully review and consider the Proposal and pursue the course of action that it believes is in the best interests of Allergan's stockholders. Allergan also adopted a one-year Stockholder Rights Plan effective April 22, 2014.
Co issues guidance for Q2, sees EPS of $1.41-1.44 vs. $1.37 Capital IQ Consensus; sees Q2 total product net sales of $1.725-1.80 bln, may not be comparable to $1.74 bln Capital IQ Consensus Estimate.

Co issues guidance for FY14, raises EPS to $5.64-5.73 from $5.36-5.48 vs. $5.48 Capital IQ Consensus; sees FY14 total product net sales of $6.775-7.0 bln, may not be comparable to $6.88 bln Capital IQ Consensus Estimate.

>>> Afren - Bought on 16th of Apr. - + 22%

Taking some profit here +22% since initiation. 
I am keeping part of position to play the top of the range (above 172).

----- Original Message -----
From: LAURENT CHEKROUN ()
To: LAURENT CHEKROUN ()
At: Apr 30 2014 09:01:09

AFREN opening much higher on HOIL take over news I will take half of profit here as yesterday target was not reach

----- Original Message -----
From: LAURENT CHEKROUN ()
To: LAURENT CHEKROUN ()
At: Apr 29 2014 16:24:12

AFR has a decent rebound today, after few days correction, the stock is breaking important levels, important resistance on 154.30/155 levels that was my target.
I will take part of profit above 154.50 but still think there is more potential, if 155 broken on close, target is 163.


----- Original Message -----
From: LAURENT CHEKROUN ()
To: LAURENT CHEKROUN ()
At: Apr 28 2014 10:45:43

AFR tested its 200d MA Last week and traded lower since that, PMO News over the Week end & Tullow article in teh Barron's are positive catalyst for the sector, Stock is testing some support , I will take profit around the 154.5 levels, if 156.75 broken next levels will be 164.

AFR is still more than 4% higher since we initiate the trade.


----- Original Message -----
From: LAURENT CHEKROUN ()
At: Apr 23 2014 13:49:29

AFR +6.8% since recommendation on the 16th, still think there is more potential even if target reached, 155 next target

----- Original Message -----
From: LAURENT CHEKROUN ()
To: LAURENT CHEKROUN ()
At: Apr 16 2014 16:46:46

* Afren enjoyed a successful year in 2013, ramping up Ebok and capping the year off with the Ogo discovery
* Kurdistan has been an early investment for Afren, and this asset could be sold and unlock value for shareholder, if no deal the stock should trade at least in line with the market
* Stock is trading with a decent discount to NPV
* 135 levels is a strong support and stock should hold these levels
* Stosk has been weak on the last few weeks and start to stabilize
* 2 brokers issued +ve recommendaation on the last 2 days (BMO & Investec)
* I see limited downside (132 level - 5% from here ) and see the stoc testing back the 145 & 149 levels.

as rumors were around on TLW stating Sinopec & Statoil could be interested, any news in the sector will push the stock higher.


--> Buy Afren

>>> US Gapping down

Gapping down

In reaction to disappointing earnings/guidance: RLOC -18.9% (also downgraded to Equal Weight from Overweight at First Analysis Sec, downgraded to Sell from Hold at Craig Hallum ), DTLK -18.3%, AVNW -17.4%, WFM -17.4% (several analyst downgrades), AEGR -16.1%, ZU -15.4%, GNC -12.3%, FEYE -11.1% (also enters agreement to acquire nPulse Technologies; financial terms not disclosed), EXTR -10.9%, OCLR -9.8%, TRMB -9.4%, MZOR -8.6%, AOL -7.6%, FNGN -7%, (light volume), GRPN -6.5%, CNVR -6.4%, (light volume), PRGO -6.3%, EXTR -6.2% (also announces departure of COO), WBAI -5%, GWPH -4.4%, ( receives Investigational New Drug From FDA for Phase 2/3 clinical trial of Epidiolex in the treatment of Dravet Syndrome), TGA -4.4%, VE -3.6%, FTR-3.5%, SFUN -3.5%, ESRT -2.5%, (light volume), SSNI -2.1%, BID -1.4%, HSBC -1.1%, CHUY -0.8%, (light volume), MYGN -0.8%, ACAD -0.8%, CODE -0.3%.

Select metals/mining stocks trading lower: BHP -1.4%, BBL -1%, GOLD -0.9%, SLV -0.5%, GLD -0.4%.

Other news: SBRA -4.8% (prices 7 mln shares of common stock at $28.35), TFM -4.4% (following WFM results; downgraded to Underperform from Neutral at Sterne Agee ), SABR -3.3% (still checking), AMTD -1.5% ( SEC is considering investigating brokerages handling of retail orders, according to reports), ETFC -1.5% ( SEC is considering investigating brokerages handling of retail orders, according to reports), YPF -1.2% (Repsol SA plans to make $622 mln capital gain from YPF sale, according to reports), AZN -1% and PFE -0.8% (Pfizer has indicated that Asterzenca takeover would help science, according to reports), FNSR -0.9% (following OCLR results), LMT -0.3% (Lockheed Martin/Boeing (BA) partnership denial will not be expanded upon by Judge, according to reports), SHLD-0.2% (planning more store closures, according to reports).

Analyst comments: INFY -3.4% (downgraded to Sell from Neutral at UBS), MRK -0.9% (downgraded to Equal-Weight from Overweight at Morgan Stanley), MAR -0.7% (downgraded to Equal Weight from Overweight at Morgan Stanley), EBAY -0.4% (downgraded to Neutral from Buy at SunTrust).

>>> US Gapping up

Gapping up

In reaction to strong earnings/guidance: EA +16.9%, ARRS +13.1%, ENPH +9.1% (light volume), OXGN +7.2% (light volume), STXS +6.7%, JIVE +6.5%, GALE +5.7%, MDLZ +5.1%, (also co is merging its coffee business with D.E Master Blenders, to be called Jacobs Douwe Egberts; announces new restructuring program), ZAGG +5% (light volume), TTGT +4.9%, (light volume),PEGA +4.6%, VSI +4.5%, FSLR +4.4%, WPX +3.9% (also plans to sell certain working interests for $355 million), PRCP +3.7%, NOA +3.5%, (light volume), ATVI +3.3%, EXAM +3%, (light volume), TRIP +2.9%, (signs exclusive offer to acquire lafourchette; terms not disclosed), IAG +2.8%, (light volume), PXD +2.6%, RDN +2.5%, (filed for a mixed securities shelf offering for an undisclosed amount), CHK +2.3%, PZZA +2.1% (light volume), DEG +2.1%, SI +2.1%, TRMR +2%, (light volume), CHK +1.9%, DVN +1.2%, DIS +1%, MRO +0.9%, NYMT +0.9%, PBPB +0.7%, CTSH +0.7%, ETP +0.4%, TRNX +0.3% (light volume), AGU +0.2%.

A few battery related names showing strength: QTWW +20.1% (partners with Ryder to offer new technology for compressed natural gas truck fleets), PLUG +2.9%, CPST +2.8%, TSLA +0.6% (Barron's profiles positive options trade on Tesla).

Select metals/mining stocks trading higher: HMY +2.5%, AUY +2.2%, SLV +1.1%, .

Select oil/gas related names showing strength: FST +4.4% (upgraded to Equal Weight from Underweight at Morgan Stanley), ECA +3.2% (Freeport-McMoRan announces agreement to sell Eagle Ford interests for $3.1 bln to a subsidiary of Encana), TOT +1.5%, STO +1.3% (starts latest Gulf of Mexico drilling campaign; Says 70% oil recovery is achievable in its Johan Sverdrup field in the Norwegian continental shelf ), SDRL +1% (Seadrill Ltd announces disclosure regarding Sevan Drilling ASA ), HFC +0.2% (upgraded to Outperform from Neutral at Credit Suisse) .

Other news: TNET +18.1% (light volume, not seeing catalyst, recent IPO), CZR +7.8% (announces comprehensive financing plan designed to position Caesars Entertainment operating co for stock listing and significant deleveraging; CEOC launches first lien incremental term loan and refinancing of all 2015 maturities), EXEL +7.4% (Exelixis presents final Phase 1b data for Cobimetinib in combination with Vemurafenib), MNGA +7.1% (Magnegas Signs New California Distributor), MNKD +5.4% (checking for catalyst-confirmed to report earnings next week on May 12), VECO +2.9% (appoints Shubham Maheshwari as Chief Financial Officer), PCRX +2.9% (still checking), PHG +2.6% (still checking), ELX +2.6% (insider buy disclosure), RYAAY +1.9% (still checking), SFNC+1.7% (announces agreement to acquire Community First Bancshares for ~$243.4 mln; transaction is expected to be immediately accretive ), HCA +1.6% (HCA lead bidder for Healthscope, according to reports out ), HLF +1.1% (entered into an agreement with Bank of America Merrill Lynch to repurchase $266 million of Herbalife's common shares), YHOO +0.7% (Alibaba files for US IPO),MMLP +0.5% (prices public offering of 3.6 mln common units at $41.51 per unit ), PCLN +0.3% (following TRIP results).

Analyst comments: HLT +2.2% (upgraded to Overweight from Equal Weight at Morgan Stanley), JCP +1.4% (upgraded to Neutral from Sell at UBS; tgt raised to $9 from $4 ), AEIS +0.2% (upgraded to Strong Buy from Outperform at Raymond James),

>>> US Gapping Up

Gapping up

In reaction to strong earnings/guidance: EA +16.9%, ARRS +13.1%, ENPH +9.1% (light volume), OXGN +7.2% (light volume), STXS +6.7%, JIVE +6.5%, GALE +5.7%, MDLZ +5.1%, (also co is merging its coffee business with D.E Master Blenders, to be called Jacobs Douwe Egberts; announces new restructuring program), ZAGG +5% (light volume), TTGT +4.9%, (light volume), PEGA +4.6%, VSI +4.5%, FSLR +4.4%, WPX +3.9% (also plans to sell certain working interests for $355 million), PRCP +3.7%, NOA +3.5%, (light volume), ATVI +3.3%, EXAM +3%, (light volume), TRIP +2.9%, (signs exclusive offer to acquire lafourchette; terms not disclosed), IAG +2.8%, (light volume), PXD +2.6%, RDN +2.5%, (filed for a mixed securities shelf offering for an undisclosed amount), CHK +2.3%, PZZA +2.1% (light volume), DEG +2.1%, SI +2.1%, TRMR +2%, (light volume), CHK +1.9%, DVN +1.2%, DIS +1%, MRO +0.9%, NYMT +0.9%, PBPB +0.7%, CTSH +0.7%, ETP +0.4%, TRNX +0.3% (light volume), AGU +0.2%.

A few battery related names showing strength: QTWW +20.1% (partners with Ryder to offer new technology for compressed natural gas truck fleets), PLUG +2.9%, CPST +2.8%, TSLA +0.6% (Barron's profiles positive options trade on Tesla).

Select metals/mining stocks trading higher: HMY +2.5%, AUY +2.2%, SLV +1.1%, .

Select oil/gas related names showing strength: FST +4.4% (upgraded to Equal Weight from Underweight at Morgan Stanley), ECA +3.2% (Freeport-McMoRan announces agreement to sell Eagle Ford interests for $3.1 bln to a subsidiary of Encana), TOT +1.5%, STO +1.3% (starts latest Gulf of Mexico drilling campaign; Says 70% oil recovery is achievable in its Johan Sverdrup field in the Norwegian continental shelf ), SDRL +1% (Seadrill Ltd announces disclosure regarding Sevan Drilling ASA ), HFC +0.2% (upgraded to Outperform from Neutral at Credit Suisse) .

Other news: TNET +18.1% (light volume, not seeing catalyst, recent IPO), CZR +7.8% (announces comprehensive financing plan designed to position Caesars Entertainment operating co for stock listing and significant deleveraging; CEOC launches first lien incremental term loan and refinancing of all 2015 maturities), EXEL +7.4% (Exelixis presents final Phase 1b data for Cobimetinib in combination with Vemurafenib), MNGA +7.1% (Magnegas Signs New California Distributor), MNKD +5.4% (checking for catalyst-confirmed to report earnings next week on May 12), VECO +2.9% (appoints Shubham Maheshwari as Chief Financial Officer), PCRX +2.9% (still checking), PHG +2.6% (still checking), ELX +2.6% (insider buy disclosure), RYAAY +1.9% (still checking), SFNC +1.7% (announces agreement to acquire Community First Bancshares for ~$243.4 mln; transaction is expected to be immediately accretive ), HCA +1.6% (HCA lead bidder for Healthscope, according to reports out ), HLF +1.1% (entered into an agreement with Bank of America Merrill Lynch to repurchase $266 million of Herbalife's common shares), YHOO +0.7% (Alibaba files for US IPO), MMLP +0.5% (prices public offering of 3.6 mln common units at $41.51 per unit ), PCLN +0.3% (following TRIP results).

Analyst comments: HLT +2.2% (upgraded to Overweight from Equal Weight at Morgan Stanley), JCP +1.4% (upgraded to Neutral from Sell at UBS; tgt raised to $9 from $4 ), AEIS +0.2% (upgraded to Strong Buy from Outperform at Raymond James), 

WSJ : Mondelez Combines Coffee Business With D.E. Master Ble

Mondelez Combines Coffee Business With D.E. Master Blenders

Mondelez International Inc. on Wednesday said it has agreed to combine its coffee portfolio with D.E. Master Blenders 1753 B.V. to create a new coffee company.

The new company will be called Jacobs Douwe Egberts and will be based in the Netherlands. It is expected to have annual revenue of more than $7 billion, the companies said.

Mondelez will receive about $5 billion in cash and own a 49% equity interest in the new company.

Mondelez also reported its first-quarter results Wednesday, posting a 70% decline in net profit, reflecting a jump in interest and other expenses in the period.

>>> US Early premarket gappers

Early premarket gappers

Gapping up: EA +15.5%, ARRS +10.8%, ENPH +9.1%, CPST +9%, VSI +8.9%, QTWW +8.6%, CZR +7.8%, OXGN +7.2%, STXS +6.7%, JIVE +6.5%, GALE +5.7%, ZAGG +5%, TTGT +4.9%, PEGA +4.6%, WPX +3.9%, FSLR +3.6%, NOA +3.5%, ATVI +3.3%, PRCP +3.1%, EXAM +3%, VECO +2.9%, IAG +2.8%, PXD +2.6%, AUY +2.2%, PZZA +2.1%, TRMR +2%, PBPB +2%,SFNC +1.7%, SI +1.7%, HCA +1.6%, PLUG +1.6%, MRO +1.5%, JCP +1.4%, TRIP +1.4%, SLV +1.1%, RDN +1.1%, DIS +1%, NYMT +0.9%

Gapping down: DTLK -19.1%, RLOC -18.9%, AVNW -17.4%, AEGR -16.1%, ZU -15.4%, WFM -13.7%, OCLR -12.8%, EXTR -11.1%, EXTR -10.9%, GNC -10.7%, CODE -10.6%, FEYE -9.8%, TRMB -9.4%, FNGN -7%, GRPN -6.5%, CNVR -6.4%, INFY -5%, SBRA -4.8%, TFM -4.4%, GWPH -4.4%, GWPH -4.4%, VE -3.6%, FCEL -3.3%, BLDP -2.6%, ESRT -2.5%, AOL -2.1%, SSNI-2.1%, AMTD -1.5%, ETFC -1.5%, BHP -1.4%, HSBC -1.1%, AZN -1%, BBL -1%, FNSR -0.9%, PFE -0.8%, RIG -0.8%

(BN) *MEDA CEO DECLINES TO COMMENT ON WILLINGNESS TO SELL COMPANY

+------------------------------------------------------------------------------+

BN 05/07 09:20 *MEDA CFO: WE WILL BE LOOKING FOR TAX SYNERGIES WITH M&A BN 05/07 09:18 *MEDA CEO LOOKING FOR COMPLEMENTARY ASSETS TO CURRENT BUSINESS BN 05/07 09:12 *MEDA CEO: ACQUISITION STRATEGY IS NOT DEFENSE STRATEGY BN 05/07 09:06 *MEDA CEO DECLINES TO COMMENT ON MYLAN PROPOSAL BN 05/07 09:02 *MEDA CEO: "WE HAVE A TARGET LIST" FOR ACQUISITIONS BN 05/07 09:02 *MEDA CFO: WE ARE BUILDING UP SIZEABLE FIREPOWER FOR M&A BN 05/07 08:56 *MEDA CEO: EITHER YOU EAT OR BE EATEN; WE PREFER TO EAT BN 05/07 08:52 *MEDA CEO DIERKS SPEAKS IN CONFERENCE CALL BN 05/07 08:52 *MEDA CEO SEES NO REASON COMPANY WON'T DOUBLE IN SIZE IN 2 YRS BN 05/07 08:51 *MEDA PLANS TRANSFORMATIONAL, STRATEGIC, "MAJOR" ACQUISITIONS BN 05/07 08:50 *MEDA PLANS TRANSFORMATON, STRATEGIC, "MAJOR" ACQUISITIONS

+------------------------------------------------------------------------------+

*MEDA CEO DECLINES TO COMMENT ON WILLINGNESS TO SELL COMPANY 2014-05-07 09:17:57.364 GMT

--MAKIKO KITAMURA

-0- May/07/2014 09:17 GMT